Even though in NPM1 and DNMT3A are frequently mutated in adult AML, DNMT3A has been suggested as a follow-up marker [39], NPM1 and DNMT3A are each rarely mutated in pediatric AML [16, 40]. This evidence concerns the gene NPM1 and acute myeloid leukemia.